EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -0.7446
March 31, 2026 -1.222
December 31, 2025 -1.883
September 30, 2025 -2.378
June 30, 2025 -2.852
March 31, 2025 -3.043
December 31, 2024 -2.883
September 30, 2024 -2.562
June 30, 2024 -2.360
March 31, 2024 -2.103
December 31, 2023 -2.058
September 30, 2023 -2.710
June 30, 2023 -2.970
March 31, 2023 -3.184
December 31, 2022 -3.210
September 30, 2022 -2.933
June 30, 2022 -2.695
March 31, 2022 -2.731
December 31, 2021 -2.853
September 30, 2021 -3.250
June 30, 2021 -2.553
March 31, 2021 -2.164
December 31, 2020 -1.996
Date Value
September 30, 2020 -1.730
June 30, 2020 -2.516
March 31, 2020 -2.779
December 31, 2019 -2.687
September 30, 2019 -2.470
June 30, 2019 -2.131
March 31, 2019 -2.262
December 31, 2018 -2.336
September 30, 2018 -2.664
June 30, 2018 -2.982
March 31, 2018 -2.812
December 31, 2017 -2.992
September 30, 2017 -3.242
June 30, 2017 -3.192
March 31, 2017 -3.082
December 31, 2016 -3.03
September 30, 2016 -2.278
June 30, 2016 -4.254
March 31, 2016 -25.17
December 31, 2015 -27.12
September 30, 2015 -26.77
June 30, 2015 -24.20
March 31, 2015 -2.752

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. -1.036
Geron Corp. -0.1046
Halozyme Therapeutics, Inc. 3.347
Novavax, Inc. -1.523
AVITA Medical, Inc. -1.444